COVID-19: Vaccines and Therapeutics
The AHA released a series of public service announcements (PSA) and supporting materials that encourage people to seek the answers they need and ask the questions that will help them understand and become confident in the safety and effectiveness of COVID-19 vaccines.
Together, the 黑料正能量 Association (AHA), American Medical Association (AMA) and American Nurses Association (ANA) released a public service announcement (PSA) featuring their leaders urging the American public to ask questions, follow the science and get vaccinated. The PSA stresses that鈥
Answers to COVID-19 concerns and questions from the AHA. Vaccine Q&As including mandatory vaccines & vaccine mandates. Why you should be vaccinated?
Throughout the COVID-19 pandemic, Sutter Health has used the full breadth of our integrated system to help meet the needs of clinicians, staff and patients across Northern California. From investing in testing solutions at COVID-19鈥檚 onset, adapting swiftly to treat patients during the largest鈥
Pfizer said its COVID-19 vaccine will receive a priority review from the Food and Drug Administration, indicating that Pfizer has completed its rolling submission of its application for the vaccine鈥檚 full authorization.
A physician/chief medical social media officer at Jefferson Health posts TikTok videos to dispel myths about health care and the COVID-19 vaccine.
Trinity Health is targeting marketing and communication efforts to encourage COVID-19 vaccine confidence and administer shots to minority populations.
Alison Brisson, a member of AHA鈥檚 American Society for Health Care Engineering affiliate and director of facilities at Concord Hospital in New Hampshire, shares her reasons for getting the COVID-19 vaccine as part of AHA鈥檚 ongoing #MyWhy social media campaign to encourage vaccine confidence among鈥
The Centers for Disease Control and Prevention鈥檚 Advisory Committee on Immunization Practices will convene July 22 to discuss a pair of recent issues related to COVID-19 vaccines.
Johnson & Johnson was notified that the Food and Drug Administration now will require that the company add to the label of its COVID-19 vaccine a warning of a small, increased risk of Guillain-Barr茅 syndrome, a rare but potentially serious neurological condition.